{"pmid":32435500,"pmcid":"PMC7225402","title":"A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19.","text":["A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19.","There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This is a major challenge to global health policy. Gender diversity and inclusion within the pharmaceutical workforce is integral to optimal patient care. Women continue to be underrepresented in senior and leadership positions within pharmacy, despite outnumbering the men in the global pharmacy workforce. This commentary highlights the need towards gender equity and discusses the several key initiatives that are building momentum and making substantial progress towards this agenda in the pharmaceutical workforce.","J Pharm Policy Pract","Bukhari, Nadia","Manzoor, Mehr","Rasheed, Huma","Nayyer, Bismah","Malik, Madeeha","Babar, Zaheer-Ud-Din","32435500"],"abstract":["There is plenty of evidence to support that women leaders are needed in the health and pharmaceutical sectors, although most of the leadership positions in global health are predominantly occupied by men. This is a major challenge to global health policy. Gender diversity and inclusion within the pharmaceutical workforce is integral to optimal patient care. Women continue to be underrepresented in senior and leadership positions within pharmacy, despite outnumbering the men in the global pharmacy workforce. This commentary highlights the need towards gender equity and discusses the several key initiatives that are building momentum and making substantial progress towards this agenda in the pharmaceutical workforce."],"journal":"J Pharm Policy Pract","authors":["Bukhari, Nadia","Manzoor, Mehr","Rasheed, Huma","Nayyer, Bismah","Malik, Madeeha","Babar, Zaheer-Ud-Din"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32435500","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1186/s40545-020-00215-5","weight":0,"_version_":1667521393844027392,"score":9.490897,"similar":[{"pmid":32446594,"title":"[Health statistics and invisibility by sex and gender during the COVID-19 epidemic].","text":["[Health statistics and invisibility by sex and gender during the COVID-19 epidemic].","Reports on COVID-19 from the Spanish Health Ministry are valuable, but incomplete, with the perverse effect that the susceptibility to COVID-19 by sex is unclear. Prevalence of COVID-19 by sexes differs between countries. The trend in Spain shows an unequal pattern, initially more frequent in men, but women outnumbered them from March 31, after two weeks lockdown. Infections are more frequent in women than in men in close contact with probable/confirmed COVID-19 cases. Consistent with deaths in men, they are hospitalized more frequently than women: Significant gender differences in signs/symptoms can drive this pattern, already observed in other pathologies. In late April, excess mortality is the same in women (67%) than in men (66%). But, lack of exhaustive information on deaths from COVID-19 in non-hospitalized patients may contribute to lower notification of deaths in women. Invisibility of data by sex and gender is probably affecting negatively women with COVID -19 more than men.","Gac Sanit","Ruiz Cantero, Maria Teresa","32446594"],"abstract":["Reports on COVID-19 from the Spanish Health Ministry are valuable, but incomplete, with the perverse effect that the susceptibility to COVID-19 by sex is unclear. Prevalence of COVID-19 by sexes differs between countries. The trend in Spain shows an unequal pattern, initially more frequent in men, but women outnumbered them from March 31, after two weeks lockdown. Infections are more frequent in women than in men in close contact with probable/confirmed COVID-19 cases. Consistent with deaths in men, they are hospitalized more frequently than women: Significant gender differences in signs/symptoms can drive this pattern, already observed in other pathologies. In late April, excess mortality is the same in women (67%) than in men (66%). But, lack of exhaustive information on deaths from COVID-19 in non-hospitalized patients may contribute to lower notification of deaths in women. Invisibility of data by sex and gender is probably affecting negatively women with COVID -19 more than men."],"journal":"Gac Sanit","authors":["Ruiz Cantero, Maria Teresa"],"date":"2020-05-25T11:00:00Z","year":2020,"_id":"32446594","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.gaceta.2020.04.008","keywords":["analisis de brotes de enfermedades","covid-19","disease outbreaks analysis","disease outbreaks statistics and numerical data","estadisticas de brotes de enfermedades y datos numericos","gender","genero","sex","sexo"],"locations":["Spain"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"weight":0,"_version_":1667698385910497281,"score":157.52293},{"pmid":32501305,"pmcid":"PMC7241361","title":"Gender equity and public health outcomes: The COVID-19 experience.","text":["Gender equity and public health outcomes: The COVID-19 experience.","This paper extends the growing research on the impact of gender equity on public health outcomes using the ongoing Covid-19 pandemic as its research setting. Specifically, it introduces a conceptual model incorporating the impact of gender equity and human development on women's representation in legislature and public health expenditure, and their combined impact with human environment (population density, aging population and urban population) on important public health outcomes in the Covid-19 context, including the total number of tests, diagnosed, active and critical cases, and deaths. Data from 210 countries shows support for many of the hypothesized relationships in the conceptual model. The results provide useful insights about the factors that influence the representation of women in political systems around the world and its impact on public health outcomes. The authors also discuss implications for public health policy-makers to ensure efficient and effective delivery of public health services in future.","J Bus Res","Leung, T Y","Sharma, Piyush","Adithipyangkul, Pattarin","Hosie, Peter","32501305"],"abstract":["This paper extends the growing research on the impact of gender equity on public health outcomes using the ongoing Covid-19 pandemic as its research setting. Specifically, it introduces a conceptual model incorporating the impact of gender equity and human development on women's representation in legislature and public health expenditure, and their combined impact with human environment (population density, aging population and urban population) on important public health outcomes in the Covid-19 context, including the total number of tests, diagnosed, active and critical cases, and deaths. Data from 210 countries shows support for many of the hypothesized relationships in the conceptual model. The results provide useful insights about the factors that influence the representation of women in political systems around the world and its impact on public health outcomes. The authors also discuss implications for public health policy-makers to ensure efficient and effective delivery of public health services in future."],"journal":"J Bus Res","authors":["Leung, T Y","Sharma, Piyush","Adithipyangkul, Pattarin","Hosie, Peter"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501305","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.jbusres.2020.05.031","keywords":["covid-19","gender equity","human development","human environment","public health expenditure","public health outcomes"],"topics":["Prevention"],"weight":1,"_version_":1668804508902227968,"score":143.71597},{"pmid":32425713,"pmcid":"PMC7233240","title":"COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department.","text":["COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department.","The coronavirus disease 2019 (COVID-19) is an ongoing pandemic having caused a major health care crises across the globe.Pharmacy professionals are considered vital in preparation for optimal response to the COVID-19 pandemic. Therefore, in response to the estimated potential impact of COVID-19 on Johns Hopkins Aramco Healthcare (joint venture between Saudi Aramco and Johns Hopkins Medicine International), several initiatives were taken by the hospital's inpatient pharmacy department with focus on infection control, staffing, meeting clinical operational challenges, ethics, increased utilization of automation, and maintenance of employee wellness to prepare for this challenge. The plan implemented by the inpatient pharmacy department was prepared while incorporating information and recommendations from leading pharmacy organizations, ministry of health, institute's experience in battling another similar coronavirus (the Middle East respiratory syndrome-coronavirus) previously, and updated scientific research. The key focus areas include development of an institutionalized COVID-19 protocol, measures to improve infection control when handling and dispensing medications, modified staffing plan, system changes in peri-operative areas, keeping pharmacy professionals updated about new and scientific researches, increased utilization of automation, clinical interventions by pharmacist ensuring appropriate utilization of medications while monitoring for drug-drug interactions, adverse drug event prevention, and preparing for handling drug shortages. By implementing a robust plan, pharmacy professionals continue to show that they are an integral member of inter-professional health care teams.","Res Social Adm Pharm","Arain, Savera","Thalapparambath, Rajesh","Al Ghamdi, Fuad Hamed","32425713"],"abstract":["The coronavirus disease 2019 (COVID-19) is an ongoing pandemic having caused a major health care crises across the globe.Pharmacy professionals are considered vital in preparation for optimal response to the COVID-19 pandemic. Therefore, in response to the estimated potential impact of COVID-19 on Johns Hopkins Aramco Healthcare (joint venture between Saudi Aramco and Johns Hopkins Medicine International), several initiatives were taken by the hospital's inpatient pharmacy department with focus on infection control, staffing, meeting clinical operational challenges, ethics, increased utilization of automation, and maintenance of employee wellness to prepare for this challenge. The plan implemented by the inpatient pharmacy department was prepared while incorporating information and recommendations from leading pharmacy organizations, ministry of health, institute's experience in battling another similar coronavirus (the Middle East respiratory syndrome-coronavirus) previously, and updated scientific research. The key focus areas include development of an institutionalized COVID-19 protocol, measures to improve infection control when handling and dispensing medications, modified staffing plan, system changes in peri-operative areas, keeping pharmacy professionals updated about new and scientific researches, increased utilization of automation, clinical interventions by pharmacist ensuring appropriate utilization of medications while monitoring for drug-drug interactions, adverse drug event prevention, and preparing for handling drug shortages. By implementing a robust plan, pharmacy professionals continue to show that they are an integral member of inter-professional health care teams."],"journal":"Res Social Adm Pharm","authors":["Arain, Savera","Thalapparambath, Rajesh","Al Ghamdi, Fuad Hamed"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425713","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.sapharm.2020.05.016","locations":["Saudi Aramco"],"topics":["Prevention"],"weight":1,"_version_":1667252837660229633,"score":136.16653},{"pmid":32408842,"title":"Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.","text":["Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.","Response, action, and adaptation of the way health services are delivered will impact our ability to provide optimized and continuity of care while acting within resource constraints imposed by COVID-19. Care for patients with cancer is particularly important given increased infection rates and worse outcomes from COVID-19 in this patient population, as well as potential adverse outcomes if treatment pathways need to be compromised. In this commentary, we provide a global oncology pharmacy perspective (including both developed and developing nations) on how COVID-19 has impacted access to and delivery of cancer therapies. This perspective was prepared by the International Society of Oncology Pharmacy Practitioners, with input from national and regional oncology pharmacy practice groups (42 practice leaders from 28 countries and regions) who contributed to a snapshot survey between 10 and 22 April 2020. Specifically, we highlight challenges related to safe handling of hazardous drugs and maintaining high-quality medication safety standards that have impacted various stakeholders.","J Oncol Pharm Pract","Alexander, Marliese","Jupp, Jennifer","Chazan, Grace","O'Connor, Shaun","Chan, Alexandre","32408842"],"abstract":["Response, action, and adaptation of the way health services are delivered will impact our ability to provide optimized and continuity of care while acting within resource constraints imposed by COVID-19. Care for patients with cancer is particularly important given increased infection rates and worse outcomes from COVID-19 in this patient population, as well as potential adverse outcomes if treatment pathways need to be compromised. In this commentary, we provide a global oncology pharmacy perspective (including both developed and developing nations) on how COVID-19 has impacted access to and delivery of cancer therapies. This perspective was prepared by the International Society of Oncology Pharmacy Practitioners, with input from national and regional oncology pharmacy practice groups (42 practice leaders from 28 countries and regions) who contributed to a snapshot survey between 10 and 22 April 2020. Specifically, we highlight challenges related to safe handling of hazardous drugs and maintaining high-quality medication safety standards that have impacted various stakeholders."],"journal":"J Oncol Pharm Pract","authors":["Alexander, Marliese","Jupp, Jennifer","Chazan, Grace","O'Connor, Shaun","Chan, Alexandre"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32408842","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1177/1078155220927450","keywords":["covid-19","isopp","oncology pharmacy","pandemic","pharmacist"],"topics":["Prevention"],"weight":1,"_version_":1666897319097794561,"score":135.33087},{"pmid":32404178,"title":"Prioritizing vulnerable populations and women on the frontlines: COVID-19 in humanitarian contexts.","text":["Prioritizing vulnerable populations and women on the frontlines: COVID-19 in humanitarian contexts.","The COVID-19 outbreak has been declared a global pandemic and cases are being reported among displaced populations that are particularly vulnerable to infection. Humanitarian workers on the frontlines of the response are working in some of the most challenging contexts and also face elevated risk of contracting COVID-19 and potential stigmatization or violence in the community. Women humanitarians may be at even greater risk, but their protection is dependent on organization-specific policies and procedures. Without gender balance in leadership positions, the specific needs of women may not be prioritized and women may not be included in decision-making or design of responses. Ensuring gender equitable access to personal protective equipment and information is imperative, but additional measures must be put into place to ensure the protection of women on the frontlines while reducing COVID-19 deaths and adverse health effects among displaced populations.","Int J Equity Health","Sharma, Vandana","Scott, Jennifer","Kelly, Jocelyn","VanRooyen, Michael J","32404178"],"abstract":["The COVID-19 outbreak has been declared a global pandemic and cases are being reported among displaced populations that are particularly vulnerable to infection. Humanitarian workers on the frontlines of the response are working in some of the most challenging contexts and also face elevated risk of contracting COVID-19 and potential stigmatization or violence in the community. Women humanitarians may be at even greater risk, but their protection is dependent on organization-specific policies and procedures. Without gender balance in leadership positions, the specific needs of women may not be prioritized and women may not be included in decision-making or design of responses. Ensuring gender equitable access to personal protective equipment and information is imperative, but additional measures must be put into place to ensure the protection of women on the frontlines while reducing COVID-19 deaths and adverse health effects among displaced populations."],"journal":"Int J Equity Health","authors":["Sharma, Vandana","Scott, Jennifer","Kelly, Jocelyn","VanRooyen, Michael J"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404178","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1186/s12939-020-01186-4","keywords":["covid-19","displaced populations","essential workers","gender","gender bias","humanitarian contexts","humanitarian organizations","women"],"topics":["Prevention"],"weight":1,"_version_":1666802845265952769,"score":134.77385}]}